NEPH - Nephros, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 12.58M
Enterprise value 9.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.29
Price/book (mrq)2.35
Enterprise value/revenue 0.84
Enterprise value/EBITDA -3.59

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-30.98%
S&P500 52-week change 32.54%
52-week high 32.0200
52-week low 30.9100
50-day moving average 31.2952
200-day moving average 31.1864

Share statistics

Avg vol (3-month) 315.43k
Avg vol (10-day) 316.44k
Shares outstanding 510.48M
Implied shares outstanding 6N/A
Float 85.66M
% held by insiders 111.52%
% held by institutions 140.33%
Shares short (14 May 2023) 418.12k
Short ratio (14 May 2023) 41.98
Short % of float (14 May 2023) 40.27%
Short % of shares outstanding (14 May 2023) 40.17%
Shares short (prior month 13 Apr 2023) 422.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 309 July 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 309 July 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -49.14%
Operating margin (ttm)-26.87%

Management effectiveness

Return on assets (ttm)-14.62%
Return on equity (ttm)-27.11%

Income statement

Revenue (ttm)11.51M
Revenue per share (ttm)1.12
Quarterly revenue growth (yoy)71.20%
Gross profit (ttm)4.73M
Net income avi to common (ttm)-3.23M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.84M
Total cash per share (mrq)0.37
Total debt (mrq)931k
Total debt/equity (mrq)10.47
Current ratio (mrq)5.88
Book value per share (mrq)0.85

Cash flow statement

Operating cash flow (ttm)-1.16M
Levered free cash flow (ttm)980.5k